FAQ's About IBC Review Requirements

WCG administers Institutional Biosafety Committees (IBCs) on behalf of over 400 institutions around the world. As partners working with a broad array of sponsors, CROs, and institutions we are frequently asked to help determine whether a clinical trial requires IBC review. Our general advice on this matter is shown in this document. To request specific advice, please address any questions to IBC Services via our contact form and a member of our team will respond as soon as we receive your inquiry.